The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...
Gastounioti The National Cancer Institute, part of the National Institutes of Health (NIH), has awarded Aimilia Gastounioti a ...
A recent study suggests that a simple blood test measuring epigenetic aging could help predict breast cancer risk in older women.
To better tailor screening decisions for women 40-49 years old, Kerlikowske uses the Breast Cancer Surveillance Consortium ...
A new statistical tool that combines multiple clinical and pathologic factors with a patient's 21-gene Oncotype DX Breast Recurrence Score® result ...
Mirai uses deep learning algorithms and analyzes mammography images, through which it makes accurate predictions of ...
Figure 1: a, Penetrance estimates for breast cancer risk in women with germline BRCA1 mutations vary depending on the population used for analysis. The availability of the human genome sequence ...
Study showed online screening tool and patient education improved genetic testing completion rateSALT LAKE CITY, Jan. 21, ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced a study revealing that more patients completed ...
Winnipeg-born reporter Alison Hall was diagnosed with breast cancer after covering actress Olivia Munn’s diagnosis. Hall, 33, ...
The new NCCN Guidelines for Patients®: Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancer is available for free at NCCN/patients or via the NCCN Patient Guides for Cancer ...
The gut microbiome, or the community of microorganisms residing in the gastrointestinal tract, has emerged as an important factor in breast cancer etiology and treatment. Specifically, the impact of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback